Furthermore, excess production of CXCL10 has been shown to be deleterious to brain cells suggesting that increased production in CM patients may contribute to the neuro-pathogenesis and blood-brain barrier damage associated with CM [7]. Here, CXCL10 is linked to cutaneous mastocytosis.